Stoke Therapeutics STOK
NASDAQ STOK
$25.62 -0.39 (-1.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Sales of Property, Plant and Equipment (2019)

Updated

Stoke Therapeutics (STOK) reported Sales of Property, Plant and Equipment of -$1,000 for Q4 2019.

Analysis

Stoke Therapeutics (STOK) Sales of Property, Plant and Equipment (2019) Analysis & Trends

For FY2019, Stoke Therapeutics posted Sales of Property, Plant and Equipment of $1,000, down 90.0% from FY2018.

  • By year, Sales of Property, Plant and Equipment came in at $10,000 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Stoke Therapeutics 1.60 Bn 429.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -1,000.00
Mar 31, 2019 2,000.00
API Access

Stoke Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=STOK&period=max&api_key=YOUR_API_KEY